OverviewChartNewsTraderScreen

Goldman Sachs Put 90 MRK 21.03.20.../  DE000GJ501Y1  /

EUWAX
11/13/2024  11:20:05 AM Chg.+0.020 Bid7:07:15 PM Ask7:07:15 PM Underlying Strike price Expiration date Option type
0.210EUR +10.53% 0.210
Bid Size: 50,000		 0.220
Ask Size: 50,000		 Merck and Co Inc 90.00 USD 3/21/2025 Put
TeleTrader 10/31 Merck's Q3 sales up 4% to $16.7 billion
GlobeNewswire 7/31 Vaccinex Reports Positive Data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease
TeleTrader 7/30 Merck's Q2 sales up 7% to $16.1 billion
GlobeNewswire 7/17 Vaccinex to report topline data for SIGNAL-AD Phase 1b/2 trial of Pepinemab in Alzheimer’s Disease a...
TeleTrader 7/1 US closes higher after data
GlobeNewswire 6/27 Verizon elects Caroline A. Litchfield to its Board of Directors
GlobeNewswire 6/26 COUR Pharmaceuticals Appoints Tim Walbert to its Board of Directors
GlobeNewswire 6/11 Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next...
GlobeNewswire 6/6 Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepin...
GlobeNewswire 5/30 Monte Rosa Therapeutics Announces Leadership Team Promotions
TeleTrader 5/28 US markets turn to losses, Dow plunges 330 points
GlobeNewswire 5/28 Apogee Therapeutics Expands Board of Directors with the Appointment of Lisa Bollinger, MD
GlobeNewswire 5/23 IO Biotech to Present at Jefferies Global Healthcare Conference
GlobeNewswire 5/23 atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
GlobeNewswire 5/16 Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 5/14 IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights
GlobeNewswire 5/8 C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire 4/25 American Kidney Fund Launches National Kidney Health Equity Media Campaign
TeleTrader 4/25 Merck's Q1 sales rise by 9% to $15.8 billion
GlobeNewswire 4/24 IO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Onc...
GlobeNewswire 4/18 The New York Academy of Medicine Announces New Board of Trustee Members
GlobeNewswire 4/15 IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
GlobeNewswire 4/9 IO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer...
GlobeNewswire 4/5 IO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business Officer
GlobeNewswire 4/3 TOMI Environmental Solutions Receives Gold Safety Award from Highwire